| . | Hazard ratio . | 95% CI . | P-value . |
|---|---|---|---|
| All-cause death | |||
| BSA < 1.867 m2 | 1.977 | 1.277–3.061 | 0.0022 |
| Age (years) | 1.040 | 1.018–1.062 | 0.0003 |
| INTERMACS level 2a | 1.709 | 1.011–2.889 | 0.045 |
| COAG death | |||
| BSA < 1.867 m2 | 2.665 | 1.349–5.265 | 0.0048 |
| COAG death/uHTx | |||
| BSA < 1.867 m2 | 2.449 | 1.370–4.377 | 0.0025 |
| INTERMACS level 2a | 2.076 | 1.058–4.072 | 0.034 |
| INF death | |||
| Age (years) | 1.077 | 1.033–1.123 | 0.0005 |
| INF death/uHTx | |||
| Bridge to candidacyb | 0.493 | 0.251–0.967 | 0.040 |
| . | Hazard ratio . | 95% CI . | P-value . |
|---|---|---|---|
| All-cause death | |||
| BSA < 1.867 m2 | 1.977 | 1.277–3.061 | 0.0022 |
| Age (years) | 1.040 | 1.018–1.062 | 0.0003 |
| INTERMACS level 2a | 1.709 | 1.011–2.889 | 0.045 |
| COAG death | |||
| BSA < 1.867 m2 | 2.665 | 1.349–5.265 | 0.0048 |
| COAG death/uHTx | |||
| BSA < 1.867 m2 | 2.449 | 1.370–4.377 | 0.0025 |
| INTERMACS level 2a | 2.076 | 1.058–4.072 | 0.034 |
| INF death | |||
| Age (years) | 1.077 | 1.033–1.123 | 0.0005 |
| INF death/uHTx | |||
| Bridge to candidacyb | 0.493 | 0.251–0.967 | 0.040 |
CI: confidence interval; COAG death: death due to stroke or systemic bleeding; COAG death/uHTx: death due to stroke or systemic bleeding, or urgent heart transplantation due to difficulties of coagulation management (i.e. embolic events or bleeding); INF death: death due to sepsis; INF death/uHTx: death due to sepsis, or urgent heart transplantation due to device infection.
aINTERMACS level 2 vs levels 3 and 4.
bBridge to candidacy vs other indications.
| . | Hazard ratio . | 95% CI . | P-value . |
|---|---|---|---|
| All-cause death | |||
| BSA < 1.867 m2 | 1.977 | 1.277–3.061 | 0.0022 |
| Age (years) | 1.040 | 1.018–1.062 | 0.0003 |
| INTERMACS level 2a | 1.709 | 1.011–2.889 | 0.045 |
| COAG death | |||
| BSA < 1.867 m2 | 2.665 | 1.349–5.265 | 0.0048 |
| COAG death/uHTx | |||
| BSA < 1.867 m2 | 2.449 | 1.370–4.377 | 0.0025 |
| INTERMACS level 2a | 2.076 | 1.058–4.072 | 0.034 |
| INF death | |||
| Age (years) | 1.077 | 1.033–1.123 | 0.0005 |
| INF death/uHTx | |||
| Bridge to candidacyb | 0.493 | 0.251–0.967 | 0.040 |
| . | Hazard ratio . | 95% CI . | P-value . |
|---|---|---|---|
| All-cause death | |||
| BSA < 1.867 m2 | 1.977 | 1.277–3.061 | 0.0022 |
| Age (years) | 1.040 | 1.018–1.062 | 0.0003 |
| INTERMACS level 2a | 1.709 | 1.011–2.889 | 0.045 |
| COAG death | |||
| BSA < 1.867 m2 | 2.665 | 1.349–5.265 | 0.0048 |
| COAG death/uHTx | |||
| BSA < 1.867 m2 | 2.449 | 1.370–4.377 | 0.0025 |
| INTERMACS level 2a | 2.076 | 1.058–4.072 | 0.034 |
| INF death | |||
| Age (years) | 1.077 | 1.033–1.123 | 0.0005 |
| INF death/uHTx | |||
| Bridge to candidacyb | 0.493 | 0.251–0.967 | 0.040 |
CI: confidence interval; COAG death: death due to stroke or systemic bleeding; COAG death/uHTx: death due to stroke or systemic bleeding, or urgent heart transplantation due to difficulties of coagulation management (i.e. embolic events or bleeding); INF death: death due to sepsis; INF death/uHTx: death due to sepsis, or urgent heart transplantation due to device infection.
aINTERMACS level 2 vs levels 3 and 4.
bBridge to candidacy vs other indications.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
